Development of pemphigus vulgaris in a patient with pemphigus foliaceus: Antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay

Journal of the American Academy of Dermatology

Volumn 42, Issue 5 II, 2000, Pages 859-861

  Ishii, Ken ^a,b   Amagai, Masayuki ^a   Ohata, Yoshiyuki ^a   Shimizu, Hiroshi ^a   Hashimoto, Takashi ^c   Ohya, Kazuhiko ^d   Nishikawa, Takeji ^a  

^a KEIO UNIVERSITY   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Medical & Biological Laboratories Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLOSPORIN; DESMOGLEIN; PREDNISOLONE;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MALE; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

EID: 0034073888     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(00)90253-6     Document Type: Article

References (20)

1. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991;67:869-77.
2. Amagai M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 1996;11:319-52.
3. Iwatsuki K,Takigawa M, Hashimoto T, Nishikawa T, Yamada M. Can pemphigus vulgaris become pemphigus foliaceus? J Am Acad Dermatol 1991;25:797-800.
4. Hashimoto T, Konohana A, Nishikawa T. Immunoblot assay as an aid to the diagnoses of unclassified cases of pemphigus. Arch Dermatol 1991;127:843-7.
5. Kawana S, Hashimoto T, Nishikawa T, Nishiyama S. Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris. Arch Dermatol 1994;130:1534-8.
6. Chorzelski TP, Hashimoto T, Jablonska S, Nishikawa T, Kozlowska A, Krainska T, et al. Pemphigus vulgaris transforming into pemphigus foliaceus and their coexistence. Eur J Dermatol 1995;5: 386-90.
7. Chang SN, Kim S-C, Lee I-J, Seo S-J, Hong C-K, Park W-H. Transition from pemphigus vulgaris to pemphigus foliaceus. Br J Dermatol 1997;137:303-25.
8. Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997;159:2010-7.
9. Amagai M, Komai A, Hashimoto T, Shirakata Y, Hashimoto K, Yamada T, et al. Usefulness of enzyme-linked immunosorbent assay (ELISA) using recombinant desmoglein 1 and 3 for sero-diagnosis of pemphigus. Br J Dermatol 1999;140:351-7.
10. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999;40:167-70.
11. Transposch HD, Smith CD, Senecal J-L, Rothfield N. A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum 1984;27:121-4.
12. Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44:93-151.
13. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associates major histicompatibility complex (MHC) molecules: a mechanism for MHC-linked suspetibility to human autoimmune diseases. J Exp Med 1995;181:1597-601.
14. Niizeki H, Inoko H, Mizuki N, Inamoto N, Watanabe K, Amagai M, et al. HLA-DQA1, -DQB1, and -DRB1 genotyping in Japanese pemphigus vulgaris patients by PCR-RFLP method. Tissue Antigens 1994;44:248-51.
15. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol 1996;8:831-6.
16. Younus J, Ahmad R. The relationship of pemphigus to neoplasia. J Am Acad Dermatol 1990;23:498-502.
17. Patten SF, Dijkstra JWE. Associations of pemphigus and autoimmune disease with malignancy or thymoma. Intern J Dermatol 1994;33:836-42.
18. Sherer Y, Bar-Dayan Y, Shoenfeld Y. Thymoma, thymic hyperplasia, thymectomy and autoimmune diseases [review]. Intern J Oncol 1997;10:939-43.
19. Nagvekar N, Moody A-M, Moss P, Roxanis I, Curnow J, Beeson D, et al. A pathogenic role for thymoma in myasthenia gravis. J Clin Invest 1998;101:2268-77.
20. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999;103:461-8.